Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection

NCT04927312 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Intra-abdominal Infection

Interventions

DRUG: PF-06947386
DRUG: Metronidazole

Sponsor

Pfizer